PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25361208-5	2014	Based on IC50 values under normoxic conditions, we detected a 1.3-2.9-fold higher cytotoxicity of the BA derivatives B10 and NVX-207, respectively, compared to BA.	betulinic acid	102-104	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	117-120	
24743710-0	2014	Hypoxia enhances the antiglioma cytotoxicity of B10, a glycosylated derivative of betulinic acid.	betulinic acid	82-96	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	48-51	
24743710-1	2014	B10 is a glycosylated derivative of betulinic acid with promising activity against glioma cells.	betulinic acid	36-50	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	0-3	
22343715-0	2012	Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process.	betulinic acid	71-85	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	37-40	
23000516-2	2013	Here, we discover that the PI3K inhibitor GDC-0941 acts in concert with the natural compound B10, a glycosylated derivative of betulinic acid, to induce cell death in glioblastoma cells.	betulinic acid	127-141	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	93-96	
22343715-2	2012	B10 is a semi-synthetic glycosylated derivative of BA selected for its enhanced cytotoxic activity.	betulinic acid	51-53	ectonucleotide pyrophosphatase/phosphodiesterase 3	Homo sapiens	0-3